Press Releases

Hepion Pharmaceuticals Announces Canadian Research Team’s Academic Appointments December 3, 2019
Hepion Pharmaceuticals to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference December 3, 2019
Hepion Pharmaceuticals' CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver Disease November 20, 2019
Hepion Pharmaceuticals to Present at The Liver Meeting(R) 2019 November 7, 2019
Hepion Pharmaceuticals' CRV431 Reduces Liver Fibrosis in a Western Diet Model of NASH November 7, 2019
Hepion Pharmaceuticals to Present on CRV431 at the 3rd Annual NASH Summit October 23, 2019
Hepion Pharmaceuticals Announces Publication of Data Highlighting CRV431's Potential as a Treatment for Chronic Liver Diseases October 16, 2019
World-Renowned Liver Disease Expert, Dr. Stephen Harrison, Joins Hepion Pharmaceuticals as Consultant Medical Director October 10, 2019
Hepion Pharmaceuticals Strengthens Management Team with Three Key Promotions October 3, 2019
Hepion Pharmaceuticals to Present at the H. C. Wainwright 21st Annual Global Investment Conference September 4, 2019

Get Important News and Updates by Email Subscribe